On June 30, 2022, Bridge Biotherapeutics, Inc. closed the transaction. The company issued 292,680 shares for gross proceeds of KRW 2,999,970,000 in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,986 KRW | +0.15% |
|
-12.89% | -39.54% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,510 KRW | -0.46% | -2.98% | 73.15M | ||
3,320 KRW | +2.15% | -1.92% | 532M | ||
2,070 KRW | -1.43% | -12.29% | 79.32M | ||
1,986 KRW | +0.15% | -12.89% | 34.99M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.54% | 34.99M | |
+15.85% | 122B | |
+18.91% | 113B | |
+4.43% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-16.61% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 2.99997 billion in funding from a group of investors